{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:56:49Z","timestamp":1793912209035,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3221,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.fertnstert.2013.04.029","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T20:15:13Z","timestamp":1368216913000},"page":"430-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Predictors of ovarian response in women treated with corifollitropin alfa for in\u00a0vitro fertilization\/intracytoplasmic sperm injection"],"prefix":"10.1016","volume":"100","author":[{"given":"Nikolaos P.","family":"Polyzos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.04.029_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH\u00a0and AFC as predictors of excessive response in controlled ovarian\u00a0hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-m\u00fcllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"la Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antim\u00fcllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib5","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-m\u00fcllerian hormone and FSH:\u00a0prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/den108","article-title":"Relevance of anti-m\u00fcllerian hormone measurement in a routine IVF program","volume":"23","author":"Gnoth","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib7","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","article-title":"Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib8","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, noninferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation\u00a0using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib9","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in\u00a0vitro fertilization","volume":"89","author":"Devroey","year":"2004","journal-title":"J\u00a0Clin\u00a0Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rbmo.2012.01.005","article-title":"Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH","volume":"24","author":"Tarlatzis","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.fertnstert.2012.01.092","article-title":"Is there a place for corifollitropin alfa in IVF\/ICSI cycles? A systematic review and meta-analysis","volume":"97","author":"Mahmoud Youssef","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib13","unstructured":"European Medicines Agency. EMEA\/H\/C\/001106\u2212IG\/0117\/G. 2011. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001106\/WC500074786.pdf."},{"key":"10.1016\/j.fertnstert.2013.04.029_bib14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE\u00a0consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib15","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/humrep\/des120","article-title":"AMH for predicting poor ovarian responders in GnRH antagonist cycles","volume":"27","author":"Polyzos","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib16","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","article-title":"A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?","volume":"96","author":"Polyzos","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-m\u00fcllerian hormone\u2013based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib18","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antimullerian hormone in gonadotropin-releasing hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/uog.6310","article-title":"Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC","volume":"33","author":"Deb","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib20","first-page":"631","article-title":"Anti-m\u00fcllerian hormone: clairvoyance or crystal clear?","volume":"27","author":"Nelson","year":"2012","journal-title":"Hum\u00a0Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib21","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","article-title":"Serum anti-m\u00fcllerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib22","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal antim\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in\u00a0vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of antim\u00fcllerian hormone as a test for the prediction of ovarian reserve","volume":"90","author":"Kwee","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib24","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-free clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.029_bib25","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.fertnstert.2012.07.125","article-title":"A large double-blind efficacy and safety trial of corifollitropin alfa versus daily recombinant FSH in women 35 to 42 years of age undergoing ovarian\u00a0stimulation prior to IVF or ICSI (PURSUE trial)","volume":"98","author":"Boostanfar","year":"2012","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213005438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213005438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:34:38Z","timestamp":1771392878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213005438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0015028213005438"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.04.029","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of ovarian response in women treated with corifollitropin alfa for in\u00a0vitro fertilization\/intracytoplasmic sperm injection","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}